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ABSTRACT
U12-type introns exist, albeit rarely, in a variety
of multicellular organisms. Splicing of U12
intron-containing precursor mRNAs takes place in
the U12-type spliceosome that is distinct from the
major U2-type spliceosome. Due to incompatibility
of these two spliceosomes, alternative splicing
involving a U12-type intron may give rise to a
relatively complicated impact on gene expression.
We studied alternative U12-type intron splicing in an
attempt to gain more mechanistic insights.
First, we characterized mutually exclusive exon
selection of the human JNK2 gene, which involves
an unusual intron possessing the U12-type 50
splice site and the U2-type 30 splice site.
We demonstrated that the long and evolutionary
conserved polypyrimidine tract of this hybrid
intron provides important signals for inclusion of
its downstream alternative exon. In addition,
we examined the effects of single nucleotide
polymorphisms in the human WDFY1 U12-type
intron on pre-mRNA splicing. These results provide
mechanistic implications on splice-site selection of
U12-type intron splicing. We finally discuss the
potential effects of splicing of a U12-type intron
with genetic defects or within a set of genes
encoding RNA processing factors on global gene
expression.
INTRODUCTION
In higher eukaryotes, the majority of genes are interrupted
by multiple introns that are excised from precursor
mRNA (pre-mRNA) during gene expression. Two distinct
types of introns, namely U2 and U12, are found in the
genomes of multicellular organisms [reviewed in (1,2)].
U2-type introns predominate, whereas U12-type introns
occur with a much lower frequency and are absent in some
species such as Caenorhabditis elegans (3). The two
intron types are distinguishable by their splice site and
branch-site sequences. Almost all pre-mRNA introns have
GT and AG dinucleotides at their 50 and 30 boundaries,
respectively, except for a subgroup with the AT–AC
terminal residues (3). The U2- and U12-type introns are
spliced by their respective spliceosomes. The two types of
the spliceosome share one small nuclear ribonucleoprotein
(snRNP), U5, but each has four other speciﬁc snRNPs:
U1, U2 and U4/U6 in the U2-type spliceosome, and
their low-abundance functional analogs, namely U11,
U12 and U4atac/U6atac in the U12-type spliceosome
[reviewed in (1,2)]. Each snRNA diﬀers from its analogs in
the primary sequence but they share a remarkable
similarity in the secondary structure (1). Moreover,
the two spliceosomes contain a large common set of
protein components, and the intricate network of the
RNA–RNA interactions is strikingly similar in each
spliceosome [reviewed in (1,2,4,5)]. Nevertheless,
the individual spliceosomes can only catalyze the removal
of their cognate introns.
The U2- and U12-dependent splicing systems might
have evolved independently in separate lineages and
then merged in a eukaryote progenitor upon lineage
fusion (6). These two splicing machineries may have also
converged evolutionarily to share common protein
factors (4). Another model suggests that the two types
of spliceosomal introns may have arisen from two
diﬀerent self-splicing group II introns [reviewed in (7)].
Nevertheless, the scarcity of the U12-type introns in
modern organisms may result from their less accurate and
slower splicing as compared to the U2-type introns
[reviewed in (5)]. Thus, the U12-type introns might have
a tendency to convert their sequence to loosely deﬁned
U2-type splice site/branch sites via mutational changes
during evolution (6).
Phylogenetic analysis reveals that U12-type introns
are present in homologous genes encoded by diﬀerent
species that have diverged over 600 million years ago
[reviewed in (5)]. The presence of homologous introns in
gene family members is largely due to gene ampliﬁcation
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introns prevail in sets of genes involved in speciﬁc
cellular processes, e.g. the Ras–Raf signaling pathway
(8). Perhaps the splicing of these U12-type introns could
regulate the expression of their host genes [reviewed in
(5)]. Moreover, the persistence of U12-type introns
throughout evolution highlights their indispensable roles
in cellular functions [reviewed in (5)].
Here, a bioinformatics scan has identiﬁed a dozen
new cases of alternative splicing involving U12-type
introns, although some might result from aberrant use
of splice sites (8). Experimental results indicate that
mutations at either terminal nucleotide of U12-type
introns could activate alternative splicing via cryptic
splice-site utilization (9,10). Preferential activation of
cryptic 30 splice sites (hereafter abbreviated to SS) suggests
that the U12-type spliceosome has lower stringency in
recognition of the 30SS, as compared to the 50SS (9–11).
Notably, a mutation in the U12-type intron 50SS of the
tumor suppressor gene LKB1/Serine/threonine–protein
kinase 11 (STK11) is associated with the autosomal
dominant disorder Peutz–Jeghers syndrome (PJS), under-
scoring the relevance of nucleotide polymorphisms of
U12-type introns in human diseases involving alternative
splicing (10). An intriguing case is identiﬁed in c-Jun
N-terminal kinase (JNK)/SAPK genes, in which the
intron between two alternative exons contains the
U12-type 50SS and the U2-type branch site and 30SS
(12–14). It is predicted that this hybrid intron could drive
mutually exclusive selection of its ﬂanking exons (13,14).
However, the detailed splicing mechanism has not
yet been deciphered.
This study was aimed at understanding the
mechanisms of alternative splicing of U12-type introns.
We experimentally examined the role of cis-elements
within the U2–U12 hybrid intron of human JNK2
(c-Jun N-terminal kinase 2) on alternative exon selection
and the eﬀect of U12-type intron polymorphisms on
splicing of the human WDFY1 pre-mRNA. JNKs
function as important cellular signaling kinases in a
variety of physiological processes [(15) and reference].
WDFY1 containing WD40 repeats and a phosphatidyli-
nositol 3-phosphate (PI3)-binding FYVE-type zinc ﬁnger
(16,17) may act as a signaling factor in the PI3 kinase
signaling pathways. Therefore, it is interesting to under-
stand whether U12-type intron splicing would impact on
their gene expression. Finally, we discuss the presence of
U12-type introns in genes encoding pre-mRNA splicing
factors and its possible impact on gene expression.
MATERIALS AND METHODS
Computational analysis of U12-type introns
To expand the dataset of human U12-type introns
provided by Levine and Durbin (8), we performed a
text search based largely on their results. Both 50 and 30
splice-site sequences of 404 U12-type intron entries
were extracted from the Supplementary Table 1 of
Levine and Durbin (8) and subjected to a search in
NCBI (http://www.ncbi.nlm.nih.gov/BLAST/) and UCSC
(http://genome.ucsc.edu/cgi-bin/hgBlat) for additional
information including gene structures and splice-site
sequences. We manually annotated each putative
U12-type intron and conﬁrmed  390 members. Next,
we searched for new U12-type introns primarily within
their host gene families using the NCBI Gene and
Ensembl Gene (http://www.ensembl.org/Homo sapiens/
index.html/) databases. This search identiﬁed  110
previously undocumented human U12-type introns, yield-
ing a collection of  500 members. Note that a compre-
hensive splice-site analysis was recently performed in
ﬁve species and identiﬁed 671 U12-type introns in the
human genome (18).
We obtained the sequences of human JNK2 and its
orthologs from Ensembl (GeneView), and annotated
the hybrid intron and its ﬂanking exons by using
ExonView and GeneSeqView (Ensembl). The JNK
family genes of other species were obtained from
the orthologs hyperlinks, and their exon/intron bound-
aries were conﬁrmed by using the UCSC Genome
Bioinformatics website. Phylogenetic conservation of
the hybrid introns was analyzed by using the AlignX
program of VectorNTI (Invitrogen) with a display
window size 23. Moreover, to search for single nucleotide
Table 1. U12-type intron-containing genes involved in RNA
metabolism
Gene symbol Note
MORC3 RNA-binding protein, nuclear matrix-binding (NXP2)
NCBP1 Cap-binding protein
NCBP2 Cap-binding protein
CRNKL1 Splicing factor
FUSIP Splicing factor SRp38
HNRPL hnRNP
HNRPLL hnRNP
HNRPM hnRNP
SNRPE SmE protein
LSM5 Sm-like protein
LSM8 Sm-like protein
LSM12 Sm-like protein
ZC3H8 Potential role in cleavage and polyadenylation
PAN3 Poly(A)-speciﬁc ribonuclease subunit
RNPC3 U11/U12 snRNP 65kDa protein
THOC2 TREX (transcription/export) component
EIF3S2 Translation initiation factor 3 subunit
EIF3S12 Translation initiation factor 3 subunit
DCP2 Pre-mRNA decapping enzyme
EXO1 50 to 30 exonuclease (RNase H)
EXOSC1 Exosome component CSL4
EXOSC2 Exosome component RRP4
EXOSC5 Exosome component RRP46
UPF1 NMD factor
MARCH6 Potential role in mRNA turnover
DDX54 RNA helicase
DEADC1 Deaminase
GARS tRNA synthetase, class II
HARS tRNA synthetase, class II
HARSL tRNA synthetase, class II
BXDC5 Ribosome maturation factor RPF1
NOL1 Nucleolar protein
NOL8 Nucleolar protein
NOL11 Nucleolar protein
NOLA1 Nucleolar protein
RCL1 RNA 30-phosphate cyclase
1834 Nucleic Acids Research, 2007, Vol. 35, No. 6polymorphisms (SNPs) of the U12-type introns, 50
U12-type intron-containing genes were analyzed by
using SNPper (http://snpper.chip.org/) and Ensemble
GeneSeqView.
Plasmid construction
The JNK2 minigene reporter was constructed as follows.
Four PCR fragments of the human JNK2 gene
were ampliﬁed from HEK 293-cell genomic DNA with
restriction site-tagged primers. Three fragments contained
either a single exon (5, 7 and 8) or two alternative exons
(6a and 6b) with the hybrid intron in the middle.
Each fragment also extended upstream and downstream
from the intronic sequences by  120–200bp. The PCR
fragments were ligated and cloned into pcDNA3.1
þ
(Invitrogen), and the DNA sequence of the resulting
minigene was conﬁrmed by sequencing. To swap the two
alternative exons with their respective ﬂanking intron
sequences (Swap-EþI), the PCR fragment containing
exon 6b with a part of the introns was ligated upstream
to the fragment containing exon 6a. To swap the
exon region only, we designed two 108-bp primers,
forward exon 6a and reverse exon 6b. These two
primers covered the entire exon 6a and 6b sequences,
respectively, and contained the mutations at their 50 end
to create an Nco II site for cloning. PCR was performed
with these two primers using the JNK2 minigene as
the template. The product was used as a vector
backbone to accommodate the hybrid intron through
the engineered Nco II sites; the resulting minigene
was termed Swap-Eonly. A PCR-based method
(QuikChange; Stratagene) was used to generate polypyr-
imidine (Py)-truncated reporters; the resulting Py1,
Py2 and Py reporters lacked nucleotides 46–62, 9–40
and 9–62, upstream of exon 6b, respectively. The
AdPy reporter was obtained by insertion of the Py
tract sequence (50-tcatacttatcctgtcccttttttttcc) derived
from the ﬁrst intron of the adenovirus major late gene
into the Py reporter.
To construct the WDFY1 minigene reporter, HeLa
cell genomic DNA was used as template for PCR
ampliﬁcation of four separate fragments of WDFY1;
each fragment encompassed a single exon (4 to 7) with its
ﬂanking intron sequence of  200bp. The PCR products
were appropriately ligated and cloned into vector
pcDNA3.1
þ, and their DNA sequence was conﬁrmed.
Exogenous U12 snRNA was expressed from the
pU12-DIR2 vector under the control of the native
promoter and terminator of the U12 gene (19); expression
level of the exogenous U12 snRNA was  4-fold higher
than that of the endogenous one (19). Site-directed
mutagenesis (QuikChange) was performed to introduce
the desired mutations into the WDFY1 minigenes
and pU12-DIR2. The mutant WDFY1 minigenes used
in this study were 50 þ6CU, B-4CU, B-4CA, B-4CG
and 50Bdm (see Results section for details).
The U12 snRNA mutant contained changes at nucleotides
5 (C to A) and 22 (G to U).
Invivo splicing assay
HeLa, HEK 293 and N2A cells were cultured in
Dulbecco’s modiﬁed Eagle’s medium supplemented
with 10% fetal bovine serum (FBS) and penicillin/
streptomycin/glutamine (Invitrogen). P19 cells were main-
tained in Alpha medium (Invitrogene) containing 7.5%
bovine calf serum and 2.5% FBS. For the in vivo
splicing assay,  6 10
5 HEK 293 cells were transiently
transfected with 1.6g of reported minigene using
Lipofectamine 2000 (Invitrogen) for 24h. To examine
the compensatory eﬀect of exogenous U12 snRNA, 1mg
of the reporter and 3mg of the U12 snRNA expression
vector were co-transfected. To analyze the splicing
products, total RNA was extracted using the TRIzol
reagent (Invitrogen) and converted to ﬁrst-strand cDNA
using SuperScript III reverse transcriptase with either
oligo dT (12–18 mers; Invitrogen) or minigene-speciﬁc
BGH (50-tagaaggcacagtcgagg; Invitrogen) as primer.
To detect WDFY1 transcripts, RT was performed using
the BGH primer followed by PCR ampliﬁcation with
primers 50-gctagcatggaatttcacgtttctg (exon 4; forward)
and 50-ctcgagtcaatgatggccctgaag (exon 7; reverse).
The reverse primer was 50 end-labeled with
32P using
T4-polynucleotide kinase (New England BioLabs) and
10000cpm ( 10
8cpm permg) of labeled primer was used
for each PCR reaction. The PCR products were analyzed
by electrophoresis on a denaturing 6% polyacrylamide
gel. To detect JNK2 minigene transcripts, PCR was
performed using forward exon 5 primer (50-gatttgaagcc-
tagcaacattg) and reverse BHG primer, and the products
were digested with EcoRV before electrophoresis on
2% agarose gels. Endogenous JNK2 transcripts
were examined analogously except that exon 7 primer
(50-cagttggctgaagtttcttc) instead of BHG was used
for PCR.
RESULTS
A previous report identiﬁed  400 U12-type introns
within the human genome (8). Since database entries
continuously increase, we attempted to search for
additional human U12-type introns. By using a less
comprehensive text search (see Materials and Methods
section), our collection of human U12-type introns
was tentatively expanded to  500. The new additions
were primarily the members of the known U12-type
intron-containing gene families. In this study, we took
advantage of this pool of U12-type introns to search
for alternative splicing and nucleotide polymorphisms
of U12-type introns. We also categorized U12-type intron
host genes according to their cellular functions and
herein discuss our ﬁndings.
Alternative splicing involving aU2–U12hybrid intron
The JNK family of genes in vertebrates contains a
U2–U12 hybrid intron that possesses the U12-type 50SS
and U2-type 30 end sequence (Figure 1A). This intron
cannot be properly spliced, but, in conjunction with
its upstream U2-type or downstream U12-type introns,
it may play a role in mutually exclusive selection of
Nucleic Acids Research, 2007, Vol. 35, No. 6 1835exon 6 (12,13). This alternative splicing control generates
mRNA isoforms, some of which exhibit tissue speciﬁcity.
For example, the exon 6a-containing JNK2/SAPKa/
MAKP9 isoforms are preferentially expressed in neurons,
whereas ubiquitous transcripts contain exon 6b (15).
This observation indicates the biological importance of
the U2–U12 intron-mediated splicing control.
Previous reports have shown that neuronal expression
of exon 6a-containing JNK2 isoforms is likely to be driven
by neuron-speciﬁc Nova proteins (20,21). However,
to date, the questions as to why non-neuronal JNK2
transcripts preferentially include exon 6b and what the
role of the hybrid intron plays in alternative exon
selection have not been experimentally investigated.
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Figure 1. The role of the U2–U12 hybrid intron in alternative splicing of human JNK2 pre-mRNA. (A) Schematic diagram shows exons 5 to 7 of
JNK2. Between alternative exon 6a and 6b is the U2–U12 hybrid intron (heavy line); mutually exclusive selection of either exon generates mRNA
isoforms. The numbers indicate the exon or intron length in nucleotides. U2 and U12 splice sites are indicated by hatched and ﬁlled boxes,
respectively. The triangle indicates an EcoRV restriction site in exon 6b. Below the diagram is the sequence of the Py tract of the hybrid intron.
(B) The minigene contains exons 5 to 8 of human JNK2, in which all introns except for the hybrid one are internally truncated (length indicated by
the numbers). Transcription of the minigenes is driven by the CMV promoter. Translation start codon was in frame introduced in exon 5. Within the
hybrid intron, the vertical line and grey boxes indicate the site for exon 6a/b swap and CU-rich sequences, respectively. The E6a and E6b control
PCR products were ampliﬁed from the minigene, whereas the E6a and E6b transcripts represent the RT-PCR products that were ampliﬁed from the
JNK transcripts. EcoRV digestion of the exon 6b-containing DNA fragment (472bp) yielded two bands (294 and 178bp). The modiﬁed minigenes
are also depicted; the numbers of total and C/U residues of their polypyrimidine (Py) tract are listed. (C) Analysis of the JNK transcripts of four cell
lines. The ﬁrst four lanes show the E6a and E6b control fragments with or without EcoRV digestion. RT-PCR DNA fragments ampliﬁed from the
endogenous JNK2 transcripts were of 316bp; EcoRV digestion of the exon 6b-containing product generates two nearly comigrating fragments (cut)
of 171 and 145bp. Percentage of E6a-containing transcripts [cut/(cutþuncut) 100%] in four cell lines was measured from three independent
experiments; average with standard deviation is indicated. (D) HEK 293 cells were transfected with a minigene reporter as indicted. Total RNA was
collected 24-h post-transfection and analyzed as in panel B. Shown on the gel are uncut PCR products (634bp) and the larger digested fragment
(463bp). (E) The graph represents absolute sequence complexity (Y-axis) of a JNK2 genomic segment containing the alternative exon 6a/b and the
hybrid intron (X-axis) from eight vertebrates (human, chimp, dog, cow, rat, mouse, opossum and chicken). Conservation of the Py tracts is indicated
as percentage. (F) Model shows that mutually exclusive exon (hatched and squared boxes) selection of the JNK2 gene is driven by the U2–U12 intron
(heavy line). The Py tract (grey box) of the hybrid intron dominates over that upstream of exon 6a, thus leading to exon 6b inclusion as the default
pathway, particularly in non-neuronal cells. In neuronal cells, speciﬁc splicing activators, such as Nova, induce the use of exon 6a (21,22). On the
other hand, since several YCAY elements (vertical lines) exist in the Py tract of the hybrid intron, YCAY-binding factors (such as Nova) may
antagonize the activity of the ubiquitous CU-rich element-binding factors to reduce the utilization of exon 6b.
1836 Nucleic Acids Research, 2007, Vol. 35, No. 6We therefore set out to address these questions using a
minigene system. First, we examined alternative splicing
of JNK2 in several mammalian cell lines. RT-PCR
was performed using primers speciﬁc to common exons
5 and 7. Since an EcoRV restriction site resides within
exon 6b but not in 6a (Figure 1A), the ampliﬁed PCR
fragments containing either alternative exon can
be distinguished by EcoRV digestion (Figure 1C, control).
EcoRV-resistant products were observed in neuronal
cells (Figure 1C, P19 and N2A) but barely detected in
non-neuronal cells (HeLa and HEK 293). This result was
expected and it indicated that exon 6a is utilized in
neuronal JNK2 transcripts. Moreover, predominant
expression of the exon 6b-containing isoforms in HeLa
and HEK 293 cells suggests that exon 6b selection is a
default splicing pathway in cells lacking speciﬁc splicing
regulators such as Nova proteins (20,21).
Next, we established a JNK2 minigene to examine
whether the hybrid intron determines exon 6 selection.
The minigene contained a genomic fragment of human
JNK2 from exon 5 to exon 8, within which all introns
except for the hybrid one were internally truncated
(Figure 1B). Expression of the JNK2 minigene in HEK
293 cells was examined by RT-PCR-EcoRV digestion.
As observed with endogenous JNK2 (Figure 1C),
the minigene transcripts exclusively contained exon 6b
but not 6a in HEK 293 cells (Figure 1D, WT). We then
swapped exon 6a and 6b, each together with a part of its
adjacent introns, in the minigene to examine whether
exon 6a is thus activated in HEK 293 cells (Figure 1B,
Swap-EþI). Note that the intron between the swapped
exons still remained as a hybrid, i.e. the U12-type 50SS
and U2-type 30SS. The result showed that exon 6b
still dominated over 6a in the JNK2 transcripts
(Figure 1D), indicating that utilization of exon 6 in
HEK 293 cells is not determined by its position
but perhaps by its sequence. To distinguish whether
exon 6b or its adjacent intron sequence provides putative
signals for exon choice, another swapping minigene was
constructed, in which only the alternative exon parts
were exchanged (Figure 1B, Swap-Eonly). Splicing of
this minigene transcript showed exclusive use of exon 6a
(Figure 1D), indicating that intron instead of exon
sequence contributes to the alternative exon selection
at least in a non-neuronal cell line. We noted that the
polypyrimidine (Py) tract of the hybrid intron is
unusually long and it shows a higher degree of conserva-
tion across several vertebrate species (Figure 1E; 67.6%
conservation vs 15–25% conservation of several other
JNK2 introns). Moreover, as compared to the intron
upstream of exon 6a, the hybrid intron has a higher C/U
content in the Py tract (Figure 1B, 26 C/Us in the 30 66
nucleotides of intron 5 vs 50 in the hybrid intron).
To examine whether the Py tract of the hybrid
intron contributes to default utilization of exon 6b,
we made several deletion mutants of the minigene
(Figure 1B). Figure 1D shows that a partial Py sequence
still retained the full activity for exon 6b inclusion
(Py1 and Py2), whereas deletion of an entire Py tract
drove a complete switch from exon 6b to 6a (Py).
Nevertheless, a heterologous Py tract, derived from an
intron of the adenovirus major late transcript, completely
restored the use of exon 6b (Figure 1D, AdPy). Therefore,
our data suggested that a Py tract, perhaps with a
substantially high density of C/U residues, is suﬃcient to
activate exon 6b utilization in JNK2.
In summary, the Py tract of the hybrid intron provides a
signal for the default selection of exon 6b in non-neuronal
cells, perhaps by competing with the use of the 30 splice
site prior to exon 6a (Figure 1F).
Effects of SNPsin alternative splicing ofaU12-type intron
Meanwhile we also investigated genetic variations of
U12-type introns that might activate alternative splicing.
We selected  50 U12-type intron-containing genes
from the  500 member pool to search for their SNPs
within or near the splice-site or branch-site sequences
of the U12-type introns. In addition to LKB1 (10),
our analysis identiﬁed SNPs in the U12-type intron of
another gene, WDFY1. The WDFY1 gene encodes a
previously uncharacterized protein containing WD40
repeats and a zinc ﬁnger for PI3 binding (16,17).
The two variable nucleotides detected in the WDFY1
U12-type intron are located within the 50SS consensus
and upstream of the branch site. Nucleotide polymorph-
isms in the intron consensus sequences could directly
aﬀect pre-mRNA splicing, resulting in diﬀerential levels of
isoforms between individuals (22). Since U12-type introns
exist in a number of genes encoding WD repeat-proteins
and PI3 signaling factors (8), we therefore went on to
characterize the eﬀects of the detected U12-type intron
SNPs on splicing of the WDFY1 pre-mRNA.
Cryptic 50SS utilization is induced by a mutation in
the 50SS consensus sequence of the U12-type
intron. Apparently, the detected polymorphisms in the
WDFY1 U12-type intron include nucleotide 6 of the 50SS
(refSNP:rs604990) and nucleotide 14 upstream of
the branch site (refSNP:rs530065) (Figure 2A; hereafter
termed 50 þ6 and B-14, respectively). A minigene con-
struct was created containing WDFY1 exons 4 to 7 with
internally truncated introns between these exons
(Figure 2B). The wild-type minigene was transiently
transfected into HEK 293 cells, and the RNA products
were analyzed by RT-PCR using
32P-labeled primers.
A major cDNA product (band a) corresponded to the
correctly spliced mRNA, as conﬁrmed by sequencing
(Figure 2C, lane 2). Nucleotide 6 of intron 5 was then
changed from C to U to match the detected SNP at
the 50SS (50 þ6CU). With this mutant minigene,
two shorter cDNA fragments became more visible
(Figure 2C, lane 3, bands c and d) and were then
characterized as the products generated by using cryptic
50SSs in exon 5 (Figure 2B, c and d sites). Because
these cryptic 50SSs conform to the U2-type consensus,
the U12 50 þ6CU mutation might activate the U2-type
spliceosome to use cryptic 50SSs and splice them to the
30SS of the U12-type intron, which harbors the terminal
dinucleotide AG. Our results thus indicate that the 50SS
mutation at the þ6 position of a U12-type intron impairs
its recognition by the U11 snRNP and allows
Nucleic Acids Research, 2007, Vol. 35, No. 6 1837Figure 2. Eﬀects of single nucleotide polymorphisms of the human WDFY1 U12-type intron. (A) Schematic diagram shows exons 4 to 7 of
the human WDFY1 gene. Nucleotide variations were found at residue 6 (þ6) of the 50SS consensus sequence and residue 14 ( 14) upstream of the
branch site. The minigenes used for the splicing assay contain a single mutation at either the 50 þ6 or the B-4 position or dual mutations (50Bdm)
at both sites. The numbers indicate the exon or intron length in nucleotides. (B) The minigene is composed of exons 4 to 7 with internally truncated
introns (length indicated by the numbers). Translation start and stop codons are in frame at the 50 end of exon 4 and 30 end of exon 7, respectively.
The use of the cryptic splice sites b1, b2, d, c yielded aberrant transcripts (see panel C). (C) HEK 293 cells were transfected with a minigene reporter
as indicted. Total RNA was collected 24-h post-transfection and subjected to RT-PCR analysis using
32P-labeled primers. The identity of the cDNA
products is shown at the right; hatched boxes represent truncated exons. The bar graph shows the relative abundance of the major splicing products
as a percentage; the data were obtained from two to three independent experiments. The  330-bp band (asterisk) included a variety of aberrantly
spliced JNK products, none of which expressed dominantly, and therefore was tentatively ignored in the graph. (D) A U12 snRNA expression vector
was co-transfected with the wild-type or B-4CA WDFY1 minigene into HEK 293 cells. Splicing of the WDFY1 transcripts was examined as in
panel C. The bar graph is as in panel C. (E) Model shows alternative splicing of the WDFY1 U12-type intron induced by genetic mutations.
A5 0SS mutation activates cryptic U2-type 50SSs in exon 5 (upper panel). A branch-site consensus mutation promotes the use of cryptic 50SSs in
exon 5 by the U2-type spliceosome or cryptic 30SSs in exon 6 by the U2-type spliceosome (middle panel). Bottom: A double mutant is spliced only by
the U2-type spliceosome, yielding aberrant mRNA products (lower panel).
1838 Nucleic Acids Research, 2007, Vol. 35, No. 6the activation of cryptic 50SSs by the U2-type spliceosome.
This is somewhat diﬀerent from what was observed with
the ﬁrst nucleotide mutation in the LKB1 U12-type
intron, which could generate aberrant splicing products
by using various combinations of splice sites by both
types of the spliceosome (10).
A branch-site mutation of the U12-type intron causes
aberrant selection of both 50 and 30SSs. The SNP at the
B-14 site (a G to A mutation) was initially investigated
by using a minigene construct, but it had no detectable
eﬀect on splicing (data not shown). To understand more
about the impact of branch-site consensus mutations on
splicing, we generated mutations at the  4 position,
which slightly varies among U12-type introns [reviewed
in (5)]. The C to U change (B-4CU) activated bands c
and d, as observed with the 50 þ6CU mutation, and also
generated a minor product, band b (Figure 2C, lane 4).
Sequence determination revealed that band b contained
two cDNAs generated by the use of cryptic 30SSs in
exon 6 (Figure 2B, b1 and b2 sites). When the B-4C
residue was substituted by a purine, the level of these
aberrant splicing products was particularly elevated with a
concomitant decrease of the correctly spliced RNA
(Figure 2C, lanes 5 and 6 for B-4CA and B-4CG,
respectively). The cryptic 30SSs detected in exon 6 were
probably activated by the U12-type spliceosome because
the 50SS used for splicing was unchanged. Nevertheless,
the B-4 mutations in WDFY1 could also activate
cryptic 50SSs through the use of the U2-type spliceosome
(Figure 2C, lanes 4–6, bands c and d and Figure 2E).
A5 0SS and branch-site double mutation suppresses
U12-type spliceosome-mediated splicing. Next, we
examined the eﬀect of a double mutation on U12-type
intron splicing. The 50 þ6CU mutation, in conjunction
with a mild branch-site mutation, B-4CU, was introduced
into the WDFY1 minigene. With this double mutant,
bands a and b were no longer detected (Figure 2C, lane 7).
Of note, both correctly spliced mRNA (band a) and
aberrant splicing products detected in band b were
generated by the U12-type spliceosome, albeit the latter
through the use of cryptic 30SSs. Therefore, our result
indicated that the activity of the U12-type spliceosome
was completely abrogated when both the 50SS and
branch site were mutated. Moreover, bands c and d
were enhanced with the double mutant 50Bdm (Figure 2C,
lane 7), suggesting that the U2-type spliceosome over-
whelmed for splicing in this case due to complete
inactivation of the U12 splicing.
Aberrant splicing caused by a branch-site mutation can
be corrected by a compensatory U12 snRNA
mutant. The above data showed that alternative splice-
site utilization is activated by nucleotide alterations in
the 50SS or branch-site consensus sequences in WDFY1.
We next examined whether such splicing events can be
reversed by coexpression of compensatory snRNA
mutants (23). Since the 50SS sequence is sequentially
recognized by the U11 and U6atac snRNAs during
splicing [reviewed in (5)], to simplify the experiments,
we investigated a branch-site mutation. The B-4CA
mutant, which altered the utilization of both 50 and
30SSs, was subjected to experimental study. To rescue its
splicing defects, nucleotide 22 of the U12 snRNA
was changed to restore its base-pairing interaction with
the B-4CA branch site and a concomitant change at
nucleotide 5 was introduced to maintain the helix I stem
(19). The B-4CA minigene was co-transfected with the
expression vector encoding U12 snRNA. Expression of
exogenous U12 snRNA was driven by the U12 promoter
and detected by RT-PCR (data not shown). Wild-type
U12 snRNA had no signiﬁcant eﬀect on splicing of either
wild-type or B-4AC reporter (Figure 2D, lanes 3 and 6).
Overexpression of the mutant U12 snRNA slightly
increased the level of band c produced from the wild-type
reporter (Figure 2D, lane 2); this was probably due
to competition between the mutant and endogenous
wild-type U12 snRNAs. Nevertheless, the splicing defect
of B-4CA was almost completely rescued by this mutant
U12 snRNA, except for a residual amount of band c
(Figure 2D, lane 5). Thus, U12 snRNA primarily
suppressed cryptic U12 30SS utilization and acted in an
allele-speciﬁc manner, suggesting that the base-pairing
interaction between U12 snRNA and the branch site was
restored.
Taken together, our data indicated that nucleotide
alternations within the U12-type intron consensus
elements could induce cryptic-site utilization by either
type of the spliceosome (Figure 2E), and this result
is essentially consistent with the previous reports (9–11).
U12-type intronsin mRNAprocessing factors
It has been reported that U12-type introns are present in
several large gene families primarily due to gene ampliﬁ-
cation (8). Conceivably, those U12-type intron-containing
paralogs have similar cellular functions; examples
include voltage-dependent calcium channel subunits,
mitogen-activated protein kinases (MAPK), RAP guanine
nucleotide exchange factors (RAPGEF) and importin-b
family nuclear transporters (8 and Supplementary
Table 1). A previous report has indicated that U12-type
introns are over-represented in genes implicated in
Ras–Raf signaling pathways (8). We also observed that
U12-type introns prevail in some functionally but
not genetically related genes, such as those involved in
chromatin remodeling and transcriptional control
(Supplementary Table 2) and those involved in mRNA
metabolism (Table 1). Some of these mRNA processing
factors may directly participate in pre-mRNA splicing
or even in alternative splicing regulation. Moreover,
factors such as transportin and SR protein kinases
involved in cellular metabolism of splicing regulatory
factors also possess U12-type introns (8). Given that
splicing of U12-type introns is a rate-determining step
(24), expression of these genes might be controlled at
the level of pre-mRNA splicing, which could subsequently
lead to global regulation of alternative splicing (Figure 3).
If this is the case, splicing of RNPC3 that encodes
an essential splicing factor associated with the U11/U12
snRNP (25) may have a feedback control on
Nucleic Acids Research, 2007, Vol. 35, No. 6 1839U12-type intron splicing; this hypothesis remains to
be investigated.
DISCUSSION
To better understand alternative splicing of U12-type
introns, we experimentally examined alternative
splicing events that were either mediated by a U2–U12
hybrid intron or induced by genetic mutations within
the U12-type intron consensus elements. Moreover,
the presence of U12-type introns in a set of splicing
factor genes leads us to hypothesize that their splicing,
particularly removal of the U12-type intron(s), might
have some impact(s) on global gene expression.
Our analysis towards the role of a U2–U12 hybrid
intron in alternative exon selection ﬁrst reveals that the
Py tract of the human JNK2 hybrid intron is exceptionally
long and conserved and contains a high C/U content.
The experiments of exon swapping and intron truncation
and substitution provided evidence suggesting that
exon 6b inclusion, a prevalent pathway in non-neuronal
cells, primarily attributes to the Py tract of the hybrid
intron. In particular, the exon-only swapping result
could almost exclude the possibility that exonic sequences
have any signiﬁcant eﬀect on exon selection at least in
non-neuronal cells. Moreover, we hypothesize that ubi-
quitous splicing activators could bind to C/U-rich
elements within the Py tract of the hybrid intron,
leading to the default splicing (Figure 1F). On the other
hand, overexpression of neuronal Nova proteins could
induce exon 6a inclusion via binding to multiple YCAY
elements (21). Note that the hybrid intron also harbors
YCAY elements, and ﬁve of them are particularly
embedded in the Py tract (Figure 1F). Thus, it is also
possible that Nova proteins antagonize the activity of
the putative CU-element binding activators via binding
to these YCAY sites, leading to suppression of exon
6b utilization in neuronal cells (Figure 1F). Interestingly,
the Py tract prior to exon 6a, although poor in its
CU content, does not contain the Nova binding sites.
Perhaps, without competition between the Py and YCAY
elements, exon 6a can be activated in neuronal cells.
Note that some of the JNK homologs in puﬀerﬁsh
(Fugu rubripes) and zebraﬁsh (Danio rerio) contain only
one exon 6 (or equivalent), of which the upstream and
downstream introns are U2- and U12-type, respectively.
Perhaps, the hybrid intron emerged by duplication of an
ancestral exon 6 along with a part of its adjacent introns,
and its presence inevitably drove the exclusive use
of duplicated exon 6.
Nucleotide alterations at the splice-site consensus
elements of U12-type introns can activate cryptic
splice-site utilization (9–11). Our results show that a U12
50SS mutation in WDFY1 preferentially induced aberrant
50SSs through the action of the U2-type spliceosome
(Figure 2E). Therefore, consistent with previous reports
(9–11), when the U12-type spliceosome fails to recognize
altered 50SS sequence of a U12-type intron, the abundant
U2-type spliceosome may take over the 30SS of this
intron to pair it with a cryptic U2-type 50SS. Aberrant
splicing was also observed with a branch-site mutation;
however, utilization of aberrant 30SSs by the U12-type
spliceosome was particularly activated under this
condition (Figure 2E). Therefore, ineﬃcient use of a
variant branch-site sequence may drive the U12-type
spliceosome to search for an aberrant branch site/30SS for
splicing. However, the U12-type spliceosome functions
only when the 50SS can be well recognized. Perhaps
the authentic 50SS sequence provides a site for U11
snRNP binding, which allows its U12 partner to locate
an appropriate, albeit cryptic, sequence for splicing.
When a U12-type intron has mutations at both the 50SS
and branch site, the U2-type spliceosome could fully
occupy this intron and function to yield aberrant
splicing products (Figure 2E). Together, our data support
previous observations that the U12-type spliceosome
has a more stringent sequence requirement for the 50SS
than the branch site/30SS; in other words, U12-type intron
splicing can take place at variable 30SS sequences.
U12-type introns, though more conserved than U2-type
introns, have nucleotide variations in the splice-site
elements [reviewed in (5)]. In general, U12-type intron
splicing has a more stringent requirement for intronic
elements and is likely to be rate limiting in the reaction
[reviewed in (5)]. Therefore, nucleotide variations and
polymorphisms in U12-type introns might profoundly
aﬀect splicing and any combination of nucleotide
changes could exacerbate splicing defects, as evidenced
by our data (Figure 2). Moreover, we speculate that the
spectrum of splicing defects resulting from U12 intron
polymorphisms somewhat diﬀers from that of U2-type
introns because aberrant U12-type intron splicing
often generates products by use of cryptic splice sites
rather than through exon skipping (Figure 2E).
As compared with exon skipping, aberrant splice-site
utilization has a higher probability of generating
products with premature translation stop codons,
which in turn results in down-regulation of gene expres-
sion (26). We thus conclude that the splicing of U12-type
introns has a substantial impact on expression of speciﬁc
genes.
Down-regulation or
dysfunction of SF
Splicing
factor (SF)
genes 
Aberrant splicing of
target pre-mRNAs
Figure 3. U12-type introns present in splicing factor genes may impact
on gene expression. When the level or activity of a splicing factor
encoded by a U12-type intron-containing gene is altered due to
defective U12-type intron splicing (grey lines), aberrant splicing of its
target pre-mRNAs may thus be observed.
1840 Nucleic Acids Research, 2007, Vol. 35, No. 6Herein we report that U12-type introns prevail in
some genes coding for RNA processing factors; of
particular interest is a set of splicing factors that
participate in constitutive and/or regulated splicing.
Given that U12-type intron splicing is rate-limiting
(24) and less tolerant to nucleotide variations in the
splice-site and branch-site elements (10 and this study),
the yield and the quality/activity of those RNA processing
factors can thus be controlled by splicing of their
U12-type intron(s). Through the functions of these
proteins, U12-type intron splicing may have a consider-
able impact on global gene expression at the level of
alternative splicing regulation (Figure 3).
SUPPLEMENTARY DATA
Supplementary data is available at NAR online.
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